CoChat

Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease

Open access
van den Berg, M. Johanneke, van der Graaf, Yolanda, Deckers, Jaap W., de Kanter, Wanda, Algra, Ale, Kappelle, L. Jaap, de Borst, Gert J., Cramer, Maarten-Jan M., Visseren, Frank L.J. · 2019 · American Heart Journal
Cited by 77

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

AIMS: To quantify the relation between smoking cessation after a first cardiovascular (CV) event and risk of recurrent CV events and mortality. METHODS: Data were available from 4,673 patients aged 61 ± 8.7 years, with a recent (≤1 year) first manifestation of arterial disease participating in the SMART-cohort. Cox models were used to quantify the relation between smoking status and risk of recurrent major atherosclerotic cardiovascular events (MACE including stroke, MI and vascular mortality) and mortality. In addition, survival according to smoking status was plotted, taking competing risk of non-vascular mortality into account. RESULTS: A third of the smokers stopped after their first CV event. During a median of 7.4 (3.7-10.8) years of follow-up, 794 patients died and 692 MACE occurred. Compared to patients who continued to smoke, patients who quit had a lower risk of recurrent MACE (adjusted HR 0.66, 95% CI 0.49-0.88) and all-cause mortality (adjusted HR 0.63, 95% CI 0.48-0.82). Patients who reported smoking cessation on average lived 5 life years longer and recurrent MACE occurred 10 years later. In patients with a first CV event >70 years, cessation of smoking had improved survival which on average was comparable to former or never smokers. CONCLUSIONS: Irrespective of age at first CV event, cessation of smoking after a first CV event is related to a substantial lower risk of recurrent vascular events and all-cause mortality. Since smoking cessation is more effective in reducing CV risk than any pharmaceutical treatment of major risk factors, it should be a key objective for patients with vascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2019.03.019

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 77

Metadata

Authors
van den Berg, M. J., van der Graaf, Y., Deckers, J. W., de Kanter, W., Algra, A., Kappelle, L. J., de Borst, G. J., Cramer, M.-J. M., & Visseren, F. L. J.
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2019-07
Volume
213
Pages
112-122
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2941792175
Cited by
77
References
9
FWCI
4.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease. https://app.cochat.ai/papers/10.1016/j.ahj.2019.03.019
The paper
van den Berg, M. J., van der Graaf, Y., Deckers, J. W., de Kanter, W., Algra, A., Kappelle, L. J., de Borst, G. J., Cramer, M.-J. M., & Visseren, F. L. J. (2019). Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease. American Heart Journal. https://doi.org/10.1016/j.ahj.2019.03.019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.